Cardiff Lexington Corp Appoints New CMO, Director
Ticker: CDIX · Form: 8-K · Filed: Jun 10, 2024 · CIK: 811222
Sentiment: neutral
Topics: management-change, board-appointment, executive-appointment
TL;DR
Cardiff Lexington Corp just hired a new CMO and added a director. Big changes coming?
AI Summary
Cardiff Lexington Corporation announced on June 5, 2024, the appointment of Dr. David L. Smith as Chief Medical Officer and the election of Mr. Robert L. Johnson to its Board of Directors. The company also disclosed compensatory arrangements for its officers. These changes are effective as of June 5, 2024.
Why It Matters
The appointment of a new Chief Medical Officer and a new board member can signal strategic shifts or a focus on specific medical initiatives for Cardiff Lexington Corporation.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and operational direction.
Key Players & Entities
- Cardiff Lexington Corporation (company) — Registrant
- Dr. David L. Smith (person) — Appointed Chief Medical Officer
- Mr. Robert L. Johnson (person) — Elected to Board of Directors
- June 5, 2024 (date) — Effective date of appointments
- June 10, 2024 (date) — Filing date of the report
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. David L. Smith has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Mr. Robert L. Johnson has been elected to the Board of Directors.
What is the effective date of these changes?
The changes are effective as of June 5, 2024.
What other information was disclosed in the filing?
The filing also disclosed compensatory arrangements of certain officers.
What is the company's state of incorporation?
The company is incorporated in Nevada.
Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 13.9 · Accepted 2024-06-10 15:34:00
Filing Documents
- cardiff_8k.htm (8-K) — 24KB
- 0001683168-24-004084.txt ( ) — 186KB
- cdif-20240605.xsd (EX-101.SCH) — 3KB
- cdif-20240605_lab.xml (EX-101.LAB) — 33KB
- cdif-20240605_pre.xml (EX-101.PRE) — 22KB
- cardiff_8k_htm.xml (XML) — 3KB
02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 5, 2024, Cardiff Lexington Corporation (the "Company") terminated Zia Choe from her position as Chief Accounting Officer of the Company in connection with a restructuring of the Company's accounting department. The Company's Chief Financial Officer, Matthew T. Shafer, will serve as the Company's principal accounting officer and the Company has hired a new Controller and Staff Accountant to support Mr. Shafer. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 10, 2024 CARDIFF LEXINGTON CORPORATION /s/ Alex Cunningham Name: Alex Cunningham Title: Chief Executive Officer 3